The article notes the S&P 500 is up roughly 12% in 2026 despite risks from persistent inflation, high bond yields and elevated valuations. It argues two space stocks could be attractive if the market suffers a major pullback. SpaceX (SPCX), with a market capitalization of roughly $1.92 trillion, trades at about 43 times expected sales; analysts expect revenue to grow roughly 141% to about $45 billion this year, though the company is currently operating at a loss. Rocket Lab grew second-quarter revenue roughly 62% to about $234 million, with a market capitalization of roughly $30.4 billion and a valuation of about 32 times expected sales, and it is still posting net losses.
Summary written by Upside AI from the original article. Read the source for full details.
Read the original on fool.com ↗
Keywords
SpaceXRocket LabS&P 500valuation
Open a keyword to see other news on the same topic.
Related news
- History Says to Buy These Space Stocks in a Market Crash
The S&P 500 is up roughly 12% in 2026 and the Nasdaq Composite roughly 12.5%, after gaining 71% and 74% over the last half-decade. The author cites risks including persistent inflation, high bond yields, elevated valuations and AI financing concerns, and suggests a sharp market pullback could create a chance to buy space stocks. SpaceX (SPCX), with a market capitalization of roughly $1.92 trillion, trades at about 43 times this year's expected sales of roughly $45 billion, and it is currently operating at a loss with capital spending likely to keep surging. Rocket Lab grew revenue about 62% year over year in the second quarter to roughly $234 million, with a market cap near $30.4 billion, about 32 times expected sales, and still posts sizable net losses.
- Tesla Stock vs. the S&P 500: Which Investment Wins Through 2030?
The article argues Tesla trades at roughly 203 times this year's expected earnings and 13 times expected sales, a valuation that looks very expensive given gross margin pressure and a slower-than-expected robotaxi rollout. The flying Roadster, slated for production in 2028, is unlikely to make a meaningful sales or earnings contribution before 2030. The author thinks a Tesla-SpaceX merger by the end of the decade, likely an all-stock deal, is more likely than not and would be a key factor in how Tesla stock performs against the S&P 500 through 2030.
- Why Rocket Lab's Recent Fall Is Overblown
Rocket Lab shares fell more than 25% as of Oct. 16, after a small manufacturing defect pushed the Neutron rocket launch back to 2027 and Space Exploration Technologies' momentum added pressure. The author argues the drop is overblown: the company has a backlog above $2.3 billion, with about 45% expected to convert into revenue within a year. Second-quarter revenue rose 62%, and the third quarter looks set to keep that growth even without Neutron. The space systems segment, which covers components, satellites and spacecraft, remains Rocket Lab's main source of revenue. The author sees the dip as an opportunity, while noting the stock is still a high-risk investment.
- Rocket Lab Delays Neutron Again. Is the Stock in Trouble?
Rocket Lab (RKLB) shares plunged after the company said the Neutron rocket’s launch would slip to next year, one of several delays, and the stock is down close to 40% over six months. The article notes investors may shift toward Space Exploration Technologies Corp, which went public over the summer. Revenue for the quarter ended June 30 rose 62% year over year to $234 million, backlog grew 137% to just under $2.4 billion, and the company is acquiring Iridium Communications. Neutron, which can handle larger payloads than Electron, is seen as key to future profitability. The author argues the delay alone doesn’t justify selling, though the company is not yet profitable and that could take a long time to change.
- Rocket Lab Drops 6% as Citizens Cuts Target Over Neutron Delay; Planet Labs Slides 5%, SpaceX Slips
Rocket Lab shares fell 6% to $51.97 in afternoon trading after the company said the first launch of its Neutron rocket would slip from the fourth quarter of 2026 into next year. Citizens cut its price target but kept an Outperform rating, saying the delay mainly affects how quickly Rocket Lab can earn revenue from later Neutron launches. Planet Labs fell 5% and SpaceX dropped 2%, while the Procure Space ETF was down 0.9%. Rocket Lab posted Q2 revenue of $234.1 million, up 62% year over year, and a record backlog of $2.36 billion. The timing of its positive free cash flow remains tied to Neutron's first successful test launch, so the delay could push that window further out.
- Stocktwits Space Race Weekly: SPCX Weathers Selloff Better Than ASTS, RKLB And FLY — RDW Fares Best
This week SPCX fell 9%, less than ASTS (13%), RKLB and FLY (19% each), while RDW's 6.99% decline was the smallest in the group. The FCC authorized a 15,000-satellite direct-to-device constellation for SpaceX, which agreed to buy Grain Management's nationwide 800 MHz spectrum for a reported $8 billion, though the deal needs FCC approval and the company faces political scrutiny, including Ukraine's claim that service restrictions disrupted drone operations. Rocket Lab pushed Neutron's first flight to 2027 after finding air pockets in a first-stage propellant tank dome, and its shares fell 7% to $55.25, extending a seven-session losing streak. Deutsche Bank upgraded ASTS to Buy with a $93 target, while Piper Sandler downgraded it to Neutral with a $54 target. Redwire announced several updates, including about $13.8 million in additional Stalker drone orders for the National Guard.
Related markets
Latest news
- Meta’s (NASDAQ:META) Q3 2026 sales top estimates, quarterly revenue guidance slightly exceeds expectations
Meta Platforms (NASDAQ: META) reported Q3 revenue of $64.6 billion, up 26.1% year on year and about 2% above estimates. Revenue guidance for the Q4 midpoint is $74.5 billion, 1.2% above analyst expectations. GAAP EPS of $3.83 was 29.9% below consensus, due to a $9.89 billion charge tied to an agreement with 52 attorneys general to resolve teen mental health litigation, with payments of up to about $18.59 billion; excluding it, EPS would have been $7.40. Operating margin fell to 20.1% from 40.1%, and free cash flow was -$2.12 billion. Daily active people reached 3.64 billion, up 100 million year on year.
- A SpaceX-Tesla megamerger could benefit both companies and Elon Musk's personal fortune
SpaceX shares rose 8% and Tesla 3.5% after Elon Musk said each company had formed special committees to discuss a possible combination. At current market values, the merged company would be worth about $3.5 trillion, the largest deal ever, and Musk argues it makes sense because both businesses rely heavily on artificial intelligence. Musk owns 11% of SpaceX and 19% of Tesla, and a change-in-control provision in Tesla's pay plan could treat many performance targets as met in a merger, which would make him richer. Although the shares are very expensive by most measures, most analysts still call them a bargain, and many work for banks hoping to win Musk's business. Democrats have called for investigations into SpaceX's federal contracts and could scuttle plans if they win big in next month's midterm elections.
- Netflix Is Down 38% Since Completing Its 10-For-1 Stock Split. Here's Why the Sell-Off Is Worsening After Its Latest Earnings.
Netflix shares are down 37.9% since the 10-for-1 stock split was completed on November 17, 2025, as of the October 20 close. After its third-quarter 2026 report, the stock fell 5.9% to $64.62 in after-hours trading, which would mark a new two-year low. Revenue rose 11.8% year over year, and operating margin widened from 28.2% to 34.6%, but the company now expects $2.7 billion in full-year ad revenue, down from $3 billion, due to a slower rollout of ad product capabilities. Its 2026 revenue forecast of $51.1 billion sits 0.2% below the prior midpoint, and the article also points to competition from YouTube, a third price increase in under three years, and a valuation of 17 times 2027 earnings. Netflix ended the quarter with $8.19 billion in cash against $12.66 billion in long-term debt.
- Where Will Novo Stock Be in 10 Years?
Novo, a Denmark-based pharmaceutical company, reached an all-time high in 2024 but has since faced clinical and commercial setbacks and lost substantial market value over the past two years. Its diabetes products, including Ozempic and Rybelsus, and its obesity drug Wegovy remain core, but U.S. patents on the active ingredient in these drugs expire in 2032, potentially opening the door to cheaper generics. Near-term catalysts include CagriSema, which could be approved by year-end and combines semaglutide with cagrilintide, though it fell short of the 25% mean weight loss Novo had hoped for. The pipeline also includes amycretin, UBT251, and several oral weight loss candidates. The author sees the pipeline as deep but warns of rising competition from dozens of weight-loss drugs, slower market growth, and possible U.S. drug price negotiations.
- NextEra Energy ( NEE ) Q3 2026 Earnings Call Transcript
NextEra Energy reported third-quarter adjusted earnings per share of $1.24, up 9.7% year over year. Florida Power & Light's net income reached $1.62 billion, versus $1.463 billion a year earlier, while adjusted earnings at NextEra Energy Resources rose 13% to $1.247 billion. The renewables and storage backlog reached 36.7 gigawatts, and FPL raised its large load target to 8 gigawatts by 2032. Shareholders have approved the pending combination with Dominion Energy, with state regulatory reviews expected to conclude in early 2027. Management maintained its 2026 adjusted earnings guidance and is targeting the high end of the range, even though wind generation in Q4 is projected to fall to 90% to 95% of the long-term average due to El Niño.
- Amazon logistics automation offers long-term margin gains, Jefferies says
Jefferies says Amazon's warehouse automation and expanding logistics network could lift retail margins long term by reducing labour dependence. Amazon has deployed over 1 million robots, but only 40% to 45% of its US small-sortable fulfillment centers are highly automated, leaving room for growth. A US$1 hourly wage rise would add about US$1.1 billion to costs, and Amazon has around US$27 billion of visible capex planned for automation and delivery. Jefferies sees third-party parcel delivery as a growth area, with US delivery stations possibly growing from about 575 to 950 by 2030 and early trials showing 20% to 25% savings for shippers. Grocery is harder given US$10 to US$12 delivery cost per order, though the broker sees potential in Amazon's planned Illinois hybrid retail concept expected in 2028.
Get the briefing on Telegram or Zalo
Join the Upside Telegram channel or Zalo group for the Vietnam stocks and gold briefing at 8:00 and 19:00 (Vietnam time) on trading days, plus a weekly wrap on Saturday morning.